efalizumab - subcutaneous injection, Raptiva
GENERIC NAME: EFALIZUMAB - SUBCUTANEOUS INJECTION (EF-a-LIZ-ue-mab)
BRAND NAME(S): Raptiva
WARNING: Efalizumab decreases immune system function (immunosuppression), which can result in very serious (possibly fatal) infections (e.g., tuberculosis, meningitis, PML), or a worsening of an existing infection. Seek immediate medical attention if you develop signs of serious infection such as persistent fever/cough, difficulty breathing, confusion, loss of balance, sudden vision/speech problems.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index